EUVIMEDEUVIMED entdecken
Scoping Review

Adverse Drug Reactions in Children with Congenital Heart Disease: A Scoping Review

Esmaeel Toni, Haleh Ayatollahi, Reza Abbaszadeh, Alireza Fotuhi Siahpirani

Pediatric Drugs · 2024-09 · 26 (5) · 519-553

DOI: 10.1007/s40272-024-00644-8 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Pediatric Drugs, online erschienen am 23.07.2024. Verfasst von Esmaeel Toni und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Informatics, Student Research Committee, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Heart Defects, Congenital, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 143 Literaturangaben. Gefördert von: Iran University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Congenital heart disease (CHD) is one of the leading causes of death. Safe and timely medical interventions, especially in children, can prolong their survival. The drugs prescribed for children with CHD are mainly based on the outcomes of drug therapy in adults with cardiovascular diseases, and their adverse drug reactions (ADRs) might be different. Therefore, the aim of this study was to investigate ADRs in children with CHD. METHODS: This was a scoping review conducted in 2023. PubMed, Web of Science, Scopus, the Cochrane Library, Ovid, ProQuest, and Google Scholar databases were searched. All studies that reported ADRs for children with CHD and were published in English by 1 November 2023 were included in this study. Finally, the results were reported using a content analysis method. RESULTS: A total of 87 articles were included in the study. The results showed that symptoms/signs/clinical findings, and cardiovascular disorders were the most common ADRs reported in children with CHD. The results also showed that most of the ADRs were reported for prostaglandin E1, amiodarone, prostaglandin E2, dexmedetomidine, and captopril, respectively. CONCLUSION: The review underscores the wide array of ADRs in children with CHD, particularly in antiarrhythmics, diuretics, beta-blockers, anticoagulants, and vasodilators, which affected cardiovascular, respiratory, endocrine, metabolic, genitourinary, gastrointestinal, and musculoskeletal systems. Tailored treatment is imperative, considering individual patient characteristics, especially in the vulnerable groups. Further research is essential for optimizing dosing, pharmacogenetics, and alternative therapies to enhance patient outcomes in CHD management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Defects, CongenitalDrug-Related Side Effects and Adverse ReactionsHumansChild

Autor:innen und Institutionen

  • Medical Informatics, Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
  • Medical Informatics, Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran. ayatollahi.h@iums.ac.ir.
  • Pediatric Cardiology, Heart Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Department of Bioinformatics, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.

Förderung

  • Iran University of Medical Sciences

Zitieren

APA

Toni, E., Ayatollahi, H., Abbaszadeh, R., & Fotuhi Siahpirani, A. (2024). Adverse Drug Reactions in Children with Congenital Heart Disease: A Scoping Review. Pediatric Drugs, 26(5), 519-553. https://doi.org/10.1007/s40272-024-00644-8

Vancouver

Toni E, Ayatollahi H, Abbaszadeh R, Fotuhi Siahpirani A. Adverse Drug Reactions in Children with Congenital Heart Disease: A Scoping Review. Pediatric Drugs. 2024;26(5):519-553. doi:10.1007/s40272-024-00644-8

BibTeX
@article{Toni2024,
  author = {Toni, Esmaeel and Ayatollahi, Haleh and Abbaszadeh, Reza and Fotuhi Siahpirani, Alireza},
  title = {Adverse Drug Reactions in Children with Congenital Heart Disease: A Scoping Review},
  journal = {Pediatric Drugs},
  year = {2024},
  volume = {26},
  number = {5},
  pages = {519--553},
  doi = {10.1007/s40272-024-00644-8}
}
Kostenlos starten →